PTPN22 and type 1 diabetes mellitus: We propose that the T1D-associated risk allotype of PTPN22 permits excessive innate and adaptive immune signaling in response to aseptic and/or septic stress/danger signals, in turn, driving a type IV delayed hypersensitivity response against pancreatic β cell antigens.